39061-98-8Relevant academic research and scientific papers
Pyrazolobenzodiazepines: Part I. Synthesis and SAR of a potent class of kinase inhibitors
Liu, Jin-Jun,Daniewski, Irena,Ding, Qingjie,Higgins, Brian,Ju, Grace,Kolinsky, Kenneth,Konzelmann, Fred,Lukacs, Christine,Pizzolato, Giacomo,Rossman, Pamela,Swain, Amy,Thakkar, Kshitij,Wei, Chung-Chen,Miklowski, Dorota,Yang, Hong,Yin, Xuefeng,Wovkulich, Peter M.
scheme or table, p. 5984 - 5987 (2010/10/21)
A novel series of pyrazolobenzodiazepines 3 has been identified as potent inhibitors of cyclin-dependent kinase 2 (CDK2). Their synthesis and structure-activity relationships (SAR) are described. Representative compounds from this class reversibly inhibit CDK2 activity in vitro, and block cell cycle progression in human tumor cell lines. Further exploration has revealed that this class of compounds inhibits several kinases that play critical roles in cancer cell growth and division as well as tumor angiogenesis. Together, these properties suggest a compelling basis for their use as antitumor agents.
6-(O-Halophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]-benzodiazepine
-
, (2008/06/13)
6-(o-halophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]-benzodiazepines of the following formula: STR1 wherein the substituent "Hal" is either of the halogens having an atomic number up to 35, inclusive, i.e., fluoro, chloro or bromo, and their pharmacologica
